Related Experiment Video

Updated: Jun 23, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Mcl-1 is required for melanoma cell resistance to anoikis

Karen Boisvert-Adamo1, Whitney Longmate, Ethan V Abel

  • 1Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Molecular Cancer Research : MCR
|April 18, 2009
PubMed

Insights

Targeting Mcl-1 sensitizes melanoma cells to anoikis, a form of apoptosis. This finding suggests Mcl-1 inhibitors may be effective melanoma treatments, especially combined with agents disrupting fibronectin-integrin signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Research

Background:

  • Melanoma is an aggressive cancer resistant to apoptosis.
  • Mutant B-RAF kinase drives melanoma growth and anoikis resistance.
  • BH3-only proteins regulate apoptosis by interacting with Bcl-2 family proteins.

Purpose of the Study:

  • To investigate the role of Mcl-1 in melanoma anoikis resistance.
  • To elucidate the mechanisms of Mcl-1 up-regulation in melanoma.
  • To explore therapeutic strategies targeting Mcl-1 in melanoma.

Main Methods:

  • RNA interference to deplete Mcl-1, Bcl-2, and Bcl-(XL).
  • Analysis of apoptosis induction in melanoma cells under different adhesion conditions.
  • Western blotting and pathway analysis to study Mcl-1 regulation.

Main Results:

  • Mcl-1 depletion sensitized B-RAF-mutant melanoma cells to anoikis.
  • Bcl-2 and Bcl-(XL) depletion had minor effects on anoikis sensitivity.
  • Mcl-1 expression is elevated in melanoma and regulated by the B-RAF pathway.
  • Fibronectin adhesion protected Mcl-1 knockdown cells from apoptosis.
  • Bad expression enhanced apoptosis in nonadherent Mcl-1 knockdown cells.

Conclusions:

  • Mcl-1 plays a critical role in melanoma cell survival and anoikis resistance.
  • The B-RAF-MEK-ERK pathway regulates Mcl-1 protein stability.
  • BH3 mimetics targeting Mcl-1, combined with fibronectin-integrin pathway inhibitors, show therapeutic potential for melanoma.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...